Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA approvals
Pharma
Lilly secures FDA nod for atopic dermatitis therapy Ebglyss
Three years after starting an immunology unit, Lilly has gained its third FDA approval in the specialty area with a nod for Ebglyss to treat eczema.
Kevin Dunleavy
Sep 16, 2024 11:16am
J&J's Tagrisso challenger wins FDA nod in first-line lung cancer
Aug 20, 2024 10:26am
Incyte, Syndax bag FDA nod for potential GvHD blockbuster
Aug 14, 2024 5:15pm
Novartis’ Fabhalta wins expanded FDA nod in IgAN
Aug 8, 2024 3:18am
In a first, FDA approves Servier's Voranigo in low-grade gliomas
Aug 6, 2024 5:25pm
FDA signs off on first engineered cell therapy for a solid tumor
Aug 2, 2024 8:56am
